Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model

BACKGROUND: Proveblue®, a methylene blue dye that complies with European Pharmacopoeia and contains limited organic impurities and heavy metals of recognized toxicity, showed in vitro synergy against Plasmodium falciparum when combined with atorvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-Co...

Full description

Saved in:
Bibliographic Details
Main Authors: Dormoi, Jérome, Briolant, Sébastien, Desgrouas, Camille, Pradines, Bruno
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637457/
https://ncbi.nlm.nih.gov/pubmed/23587099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-127
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items